tiprankstipranks
pc:cutis

CUTISS

CUTISS is a pioneering TechBio company specializing in tissue therapeutics and regenerative medicine. The company is advancing its lead product, denovoSkin™, a bio-engineered, personalized skin graft designed to enhance skin surgery outcomes. CUTISS is also developing the world's first automated manufacturing platform for personalized tissue therapy, aiming to scale production and commercialization. Additionally, CUTISS is expanding its international presence with a planned production facility in the Netherlands, in collaboration with Rode Kruis Ziekenhuis, a leading EU clinical trials center.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$56M
Total Amount Raised$56M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$56M
Latest Funding Amount$56M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 10, 2025
Series C
$56.00M

Investors

Investor Name
Funding Round

Related News and Analysis